Advertisement

Methods for the Determination of the Activity of Phospholipases and their Clinical Application

E. coli-based assay compared to a photometric micelle assay
  • Johannes Aufenanger
  • Michael Samman
  • Michael Quintel
Chapter
Part of the NATO ASI Series book series (NSSA, volume 266)

Abstract

Many assays for the determination of phospholipase A2 activity [for review: 1] have been developed. The choice of a detection method depends partly on the purpose of a particular experiment. For example, some assays can be used on purified enzymes but are incompatible with crude systems, some methods provide a continuous assay and generate a time course while others do not, and some methods are amenable to automation while others are not. However, the most important consideration in the choice of the detection method is the sensitivity required for the particular enzyme which depends on the quantity of enzyme available and on its specific activity. This point is especially important for the assay of phospholipases A2 in human plasma, which are found in lower quantities and are, in general, less active than their counterparts from venom.

Keywords

Acute Pancreatitis Pancreatic Lipase Fatty Acid Concentration Free Fatty Acid Concentration Label Fatty Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reynolds, L.J., Washburn, W.N., Deems, R.A., and Dennis, E.A., Assay strategies and methods for phospholipases. Methods Enzym. 197: 1991; 3–23CrossRefGoogle Scholar
  2. 2.
    Crowl, R.M., Stoller, T.J., Conroy, R.R., and Stoner, C.R. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266: 1991; 2647–2651PubMedGoogle Scholar
  3. 3.
    Stefanski, E., Pruzanski, W., Sternby, B., and Vadas, P. Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis. J. Biochem. Tokyo 100: 1986; 1297–1303PubMedGoogle Scholar
  4. 4.
    Elsbach, P., Weiss, J., Wright, G.W.; Forst, S., van den Bergh, C.J., and Verheij, H.M. Regulation and role of phospholipases in host-bacteria interaction. Prog. Clin. Biol. Res. 349: 1990; 1–9PubMedGoogle Scholar
  5. 5.
    Hoffmann, G.E., and Neumann, U. Modified photometric method for the determination of phospholipase A activities. Klin. Wochenschr. 67: 1989; 106–109PubMedCrossRefGoogle Scholar
  6. 6.
    Elsbach, P., Weiss, J., Franson, R.C., Beckerdite-Quagliata, S., Scheider, A., and Harris, L. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. J. Biol. Chem. 254: 1979; 11000–11009PubMedGoogle Scholar
  7. 7.
    Aufenanger, J., Zimmer, W., and Kattermann, R. Characteristics of a radiometric E.coli-based assay–Modified method for the determination of human serum phospholipase A, and its clinical application. Clin. Chem. 39: 1993; 605–613PubMedGoogle Scholar
  8. 8.
    Dole, V.P. and Meinertz, H. Microdetermination of long-chain fatty acids in plasma and tissues. J. Biol. Chem. 235: 1969; 2595–2599Google Scholar
  9. 9.
    Durst, H.D., Milano, M., Kikta, E.J., Connelly, S.A., and Grushka, E. Phenylacyl esters of fatty acids via ether catalysts for enhanced ultraviolett detection in liquid chromatography. Anal. Chem. 41: 1975; 1797–1801CrossRefGoogle Scholar
  10. 10.
    Püttmann, M., Krug, H., v. Ochsenstein, E., and Kattermann, R. Determination of serum free fatty acids in the picomol range by an easy, fast and reliable high-performance liquid chromatography method. Clin. Chem. 39: 1993; 825–832PubMedGoogle Scholar
  11. 11.
    Aufenanger, J. and Zimmer, W. 1993, Rapid isolation and purification of phospholipase A, from human serum submittedGoogle Scholar
  12. 12.
    Samman, M, Aufenanger, J. Püttmann, M., Zimmer, W., M. Quintel, and Katterman, R. Catalytically active pancreatic Phospholipase A2 as a prognostic marker in acute pancreatitis Gastroenterology: 1993 submittedGoogle Scholar
  13. 13.
    Märki, F., and Franson, R. Endogenous suppression of neutral-active and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytes. Biochim. Biophys. Acta 879: 1986; 149–156PubMedCrossRefGoogle Scholar
  14. 14.
    Waite, M. The Phospholipases. in: Handbook of Lipid Research, D J Hanahan (editor); Plenum Press, New York, Vol 5: 1987; 79–133Google Scholar
  15. 15.
    Parks, T.P., Lukas, S., and Hoffman, A.F. Purification and characterization of a phospholipase A2 from human osteoarthritic synovial fluid. in: Phospholipase A,,P.Y.K. Wong and E.A. Dennis (eds.), Plenum Press, New York, 1990; 55–81Google Scholar
  16. 16.
    Püttmann, M, Aufenanger, J., v. Ochsenstein, E., Dürholt, S., v. Ackern, K., Harenberg, J., and Hoffmann, G E Increased phospholipase A activities in sera of intensive-care patients show sn-2 specificity but no acyl-chain selectivity Clin. Chem. 39: 1993; 782–788Google Scholar
  17. 17.
    Schalkwijk, C.G., Märki, F., and Van den Bosch, H. Studies on the acyl-chain selectivty of cellular phospholipases A2. Biochim. Biophys. Acta 1044: 1990; 139–146PubMedCrossRefGoogle Scholar
  18. 18.
    Elsbach, P., Weiss, J., and Kao, L. The role of intramembrane Ca’ in the hydrolysis of the phospholipids of Escherichia coli by Ca’-dependent phospholipases. J. Biol. Chem. 260: 1985; 1618–1622PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Johannes Aufenanger
    • 1
  • Michael Samman
    • 1
  • Michael Quintel
    • 2
  1. 1.Institute for Clinical ChemistryFaculty for Clinical Medicine of the University of HeidelbergMannheimGermany
  2. 2.Institute for Clinical Anaesthesiology and Surgical Intensive Care Medicine Klinikum MannheimFaculty for Clinical Medicine of the University of HeidelbergMannheimGermany

Personalised recommendations